{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:37:13Z","timestamp":1792521433094,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06390-2","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:03:14Z","timestamp":1750665794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BRCA1 expression in ovarian cancer and its relationship with clinicopathological characteristics and prognosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Chenxiang","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"1","key":"6390_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13048-021-00911-z","volume":"14","author":"K Tanha","year":"2021","unstructured":"Tanha, K. et al. Investigation on factors associated with ovarian cancer: An umbrella review of systematic review and meta-analyses. J. Ovarian Res. 14 (1), 153 (2021).","journal-title":"J. Ovarian Res."},{"issue":"5","key":"6390_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb, P. M., Jordan, S. J. Global epidemiology of epithelial ovarian cancer. Nat. Rev. Clin. Oncol. 21 (5), 389\u2013400 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"6390_CR3","doi-asserted-by":"publisher","first-page":"e2300393","DOI":"10.1200\/GO.23.00393","volume":"10","author":"M Wang","year":"2024","unstructured":"Wang, M. et al. Global incidence of ovarian Cancer according to histologic subtype: A population-based cancer registry study. JCO Glob. Oncol. 10, e2300393 (2024).","journal-title":"JCO Glob. Oncol."},{"issue":"4","key":"6390_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1470-2045(22)00122-X","volume":"23","author":"R Kristeleit","year":"2022","unstructured":"Kristeleit, R. et al. Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): An international, open-label, randomised, phase 3 trial. Lancet Oncol. 23 (4), 465\u2013478 (2022).","journal-title":"Lancet Oncol."},{"issue":"1","key":"6390_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41467-022-28389-3","volume":"13","author":"IM Launonen","year":"2022","unstructured":"Launonen, I. M. et al. Single-cell tumor-immune microenvironment of BRCA1\/2 mutated high-grade serous ovarian cancer. Nat. Commun. 13 (1), 835 (2022).","journal-title":"Nat. Commun."},{"issue":"9","key":"6390_CR6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","volume":"20","author":"DK Armstrong","year":"2022","unstructured":"Armstrong, D. K. et al. NCCN Guidelines\u00ae insights: Ovarian cancer, version 3.2022. J. Natl. Compr. Cancer Netw. 20 (9), 972\u2013980 (2022).","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"6390_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41419-022-04510-8","volume":"13","author":"W Tian","year":"2022","unstructured":"Tian, W. et al. Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion. Cell. Death Dis. 13 (1), 64 (2022).","journal-title":"Cell. Death Dis."},{"issue":"7","key":"6390_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao, W. et al. Changing profiles of cancer burden worldwide and in china: A secondary analysis of the global cancer statistics 2020. Chin. Med. J. (Engl). 134 (7), 783\u2013791 (2021).","journal-title":"Chin. Med. J. (Engl)"},{"issue":"10","key":"6390_CR9","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1007\/s00261-024-04330-8","volume":"49","author":"NJ O\u2019Sullivan","year":"2024","unstructured":"O\u2019Sullivan, N. J. et al. Role of radiomics as a predictor of disease recurrence in ovarian cancer: A systematic review. Abdom. Radiol. (NY). 49 (10), 3540\u20133547 (2024).","journal-title":"Abdom. Radiol. (NY)"},{"issue":"2","key":"6390_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2478\/jtim-2023-0091","volume":"11","author":"L Dou","year":"2023","unstructured":"Dou, L. et al. Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism. J. Transl. Int. Med. 11 (2), 169\u2013177 (2023).","journal-title":"J. Transl. Int. Med."},{"issue":"3","key":"6390_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.gendis.2020.11.017","volume":"9","author":"C Guo","year":"2022","unstructured":"Guo, C. et al. Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine. Genes Dis. 9 (3), 668\u2013681 (2022).","journal-title":"Genes Dis."},{"key":"6390_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-031-58311-7_7","volume":"1452","author":"H Schatten","year":"2024","unstructured":"Schatten H. The impact of mitochondria in ovarian cancer cell metabolism, proliferation, and metastasis. Adv. Exp. Med. Biol. 1452, 119\u2013125 (2024).","journal-title":"Adv. Exp. Med. Biol."},{"key":"6390_CR13","doi-asserted-by":"crossref","unstructured":"Qing, X. & Liu, L. Mao X. A clinical diagnostic value analysis of serum CA125, CA199, and HE4 in women with early ovarian cancer: Systematic review and meta-analysis. Comput. Math. Methods Med. 2022, 9339325 (2022).","DOI":"10.1155\/2022\/9339325"},{"key":"6390_CR14","unstructured":"Wang, L. et al. Ultrasound-guided percutaneous biopsy combined serum CA125, CEA level examination in the diagnosis of ovarian tumors value analysis. Altern. Ther. Health Med. (2024)."},{"issue":"2","key":"6390_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cll.2023.08.004","volume":"44","author":"Z Ordulu","year":"2024","unstructured":"Ordulu, Z. & Watkins, J. Molecular pathology of ovarian epithelial neoplasms: Predictive, prognostic, and emerging biomarkers. Clin. Lab. Med. 44 (2), 199\u2013219 (2024).","journal-title":"Clin. Lab. Med."},{"key":"6390_CR16","doi-asserted-by":"crossref","unstructured":"Samuel, D. et al. Hereditary ovarian carcinoma: Cancer pathogenesis looking beyond and. Cells 11(3), (2022).","DOI":"10.3390\/cells11030539"},{"issue":"9","key":"6390_CR17","doi-asserted-by":"publisher","first-page":"101172","DOI":"10.1016\/j.gim.2024.101172","volume":"26","author":"DG Evans","year":"2024","unstructured":"Evans, D. G. et al. Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: Lower rates for 5 years post chemotherapy. Genet. Med. 26 (9), 101172 (2024).","journal-title":"Genet. Med."},{"issue":"10","key":"6390_CR18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.annonc.2022.06.011","volume":"33","author":"JS Frenel","year":"2022","unstructured":"Frenel, J. S. et al. Efficacy of subsequent chemotherapy for patients with BRCA1\/2-mutated recurrent epithelial ovarian cancer progressing on Olaparib versus placebo maintenance: Post-hoc analyses of the SOLO2\/ENGOT Ov-21 trial. Ann. Oncol. 33 (10), 1021\u20131028 (2022).","journal-title":"Ann. Oncol."},{"issue":"3","key":"6390_CR19","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ygyno.2021.12.025","volume":"164","author":"A Poveda","year":"2022","unstructured":"Povedasa, A. et al. Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1\/BRCA2 mutation: OPINION primary analysis. Gynecol. Oncol. 164 (3), 498\u2013504 (2022).","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"6390_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/jmedgenet-2021-108238","volume":"59","author":"D Grafodatskaya","year":"2022","unstructured":"Grafodatskaya, D. et al. Practice guidelines for tumour testing in ovarian cancer. J. Med. Genet. 59 (8), 727\u2013736 (2022).","journal-title":"J. Med. Genet."},{"issue":"7","key":"6390_CR21","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/carcin\/bgaa061","volume":"41","author":"KH Stopsack","year":"2020","unstructured":"Stopsack, K. H. et al. Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer. Carcinogenesis 41 (7), 904\u2013908 (2020).","journal-title":"Carcinogenesis"},{"issue":"4","key":"6390_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2478\/jtim-2024-0025","volume":"12","author":"M Ke","year":"2024","unstructured":"Ke, M. et al. Actin-related protein 2\/3 complex subunit 1B promotes ovarian cancer progression by regulating the AKT\/PI3K\/mTOR signaling pathway. J. Transl. Int. Med. 12 (4), 406\u2013423 (2024).","journal-title":"J. Transl. Int. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06390-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06390-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06390-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:03:17Z","timestamp":1750665797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06390-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6390"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06390-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study involving human participants was approved by the Medical Ethics Committee of Wenzhou Central Hospital (202411211050000078292) and was conducted in accordance with the 1964 Helsinki Declaration. And informed consent was obtained form the patients or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"20239"}}